United States Steel Corporation's stock has taken a hit following a weaker-than-expected fourth-quarter outlook, with projected losses and challenges in the steel market.
United States Steel Corporation (NYSE: X) has seen its stock decline following the announcement of a weaker-than-expected fourth-quarter outlook. The company has projected an adjusted net loss per diluted share between $0.29 and $0.25, with an adjusted EBITDA of approximately $150 million. This guidance has fallen short of previous expectations, leading to a drop in the company's stock price.
The challenges faced by U.S. Steel are multifaceted. Depressed steel prices have been a significant factor, affecting all segments of the company's operations. The North American Flat-Rolled segment, while maintaining strong EBITDA through a robust commercial strategy and diverse product mix, is still impacted by lower selling prices and volumes. The European segment is grappling with weak demand and pricing, compounded by operational disruptions due to a fire at the #1 Caster, which has necessitated the temporary operation of three blast furnaces.
Despite these challenges, U.S. Steel has completed over $4 billion in growth capital investments, with the Big River 2 (BR2) facility achieving its first coil production on October 31, 2024. However, the ramp-up costs associated with BR2 have added pressure to the company's financials, with approximately $50 million in start-up and ramp-related costs expected in the fourth quarter.
The company's Tubular segment is expected to perform better than the previous quarter, primarily due to increased volume and lower costs from the absence of outage activity. However, the overall market conditions remain challenging, with the steel industry experiencing a cyclical downturn.
U.S. Steel's stock has reacted to this news, with shares trading down 4.54% in after-hours trading, reflecting investor concerns over the company's near-term profitability and market conditions. The company is set to report its full fourth-quarter financial results at the end of January, with analysts currently expecting revenue of $3.69 billion.
As U.S. Steel navigates these challenges, the focus remains on optimizing operations and managing costs to weather the current market environment. The company's strategic investments in growth and innovation are aimed at positioning it for long-term success, despite the immediate pressures.
Party City, a leading retailer in the party supplies industry, has announced the closure of all its stores following financial struggles and a recent bankruptcy filing. The company, which has been in business for nearly 40 years, cited inflation and decreased consumer spending as key factors in its decision to wind down operations.
Honda and Nissan are reportedly in talks for a potential merger to address challenges in the automotive industry, including competition from electric vehicle manufacturers.
Google proposes to modify its search engine agreements to address US antitrust concerns, while planning to appeal the ruling.
The US FDA has approved Novo Nordisk's Alhemo, a groundbreaking treatment for hemophilia A and B with inhibitors, marking a significant advancement in hemophilia care.
The US FDA has declined to approve Lexicon Pharmaceuticals' Zynquista as an add-on treatment for type 1 diabetes and chronic kidney disease, prompting the company to shift focus to other drug candidates.
Sarepta Therapeutics Inc. has secured a $115.2 million verdict against Nippon Shinyaku Co. Ltd. for patent infringement related to its Duchenne muscular dystrophy drug, Vyondys 53.
A US jury remains deadlocked in the high-stakes trial between Arm Holdings and Qualcomm over a licensing dispute involving Nuvia's chip designs, with deliberations ongoing.
Netflix has acquired the exclusive U.S. broadcasting rights for the FIFA Women's World Cup in 2027 and 2031, marking a significant move into live sports for the streaming giant.
Carnival Corporation & plc has reported record earnings for 2024, surpassing guidance and setting a positive outlook for 2025 with expected earnings growth and strong booking volumes.